Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor.

Endocrinology | 2017

Growth hormone receptor (GHR) and prolactin (PRL) receptor (PRLR) are homologous transmembrane class I cytokine receptors. In humans, GH interacts with GHR homodimers or PRLR homodimers and PRL interacts with only PRLR homodimers to promote signaling. In human breast cancer cells endogenously expressing both receptors, GHR and PRLR specifically coimmunoprecipitate. We previously devised a split luciferase complementation assay to study GHR and PRLR assemblages. In this technique, firefly luciferase is split into two fragments (N- and C-terminal fragments of the luciferase), each without enzyme activity and tethered to the tails of two receptors. The fragments restore luciferase activity when brought close to each other by the receptors. Real-time ligand-induced complementation changes reflect the arrangement of receptors and indicate that GHR/PRLR is arranged as a heteromultimer comprised of GHR-GHR homodimers and PRLR-PRLR homodimers. We now dissect determinants for GHR and PRLR homodimerization versus heteroassociation. GHR and PRLR have extracellular domains comprised of the ligand-binding N-terminal subdomain 1 and a membrane-proximal subdomain 2 (S2), which fosters receptor-receptor contact. Based on previous studies of S2 versus the transmembrane domain (TMD) in GHR dimerization, we constructed GHR(PRLRS2), GHR(PRLRS2-TMD), and GHR(PRLRTMD), replacing GHR's S2 alone, S2 plus TMD, and TMD alone with PRLR's counterpart. We tested by complementation the ability of these chimeras and GHR or PRLR to homodimerize or heteroassociate. Comparing various combinations, we found GHR(PRLRS2) and GHR(PRLRS2-TMD) behaved as PRLR, whereas GHR(PRLRTMD) behaved as GHR regarding their dimerization partners. We conclude that S2 of GHR and PRLR, rather than their TMDs, determines their dimerization partner.

Pubmed ID: 28977606 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GST (B-14) (antibody)

RRID:AB_627677

This monoclonal targets GST (B-14)

View all literature mentions

PRL-R (H-300) (antibody)

RRID:AB_2237692

This polyclonal targets DDR1

View all literature mentions

anti-GHR cyt-mAb (antibody)

RRID:AB_2665408

This monoclonal targets GHR residues 271-620

View all literature mentions

anti-GHR ext-mAb (antibody)

RRID:AB_2665407

This monoclonal targets Rabbit GHR residues 1-245

View all literature mentions

Anti-Luciferase pAb (antibody)

RRID:AB_430862

This polyclonal targets Luciferase pAb

View all literature mentions

Anti-phospho-JAK2 (Tyr1007/1008) (antibody)

RRID:AB_310746

This polyclonal targets JAK2, phospho (Tyr1007 / Tyr1008)

View all literature mentions

anti-PRLR cyt-AL84 (antibody)

RRID:AB_2665406

This polyclonal targets PRLR

View all literature mentions

anti-JAK2 AL33 (antibody)

RRID:AB_2665398

This polyclonal targets JAK2

View all literature mentions

AL47 Antibody (antibody)

RRID:AB_2661849

This polyclonal targets GHR

View all literature mentions

Anti-Luciferase pAb (antibody)

RRID:AB_430862

This polyclonal targets Luciferase pAb

View all literature mentions

Anti-phospho-JAK2 (Tyr1007/1008) (antibody)

RRID:AB_310746

This polyclonal targets JAK2, phospho (Tyr1007 / Tyr1008)

View all literature mentions

anti-PRLR cyt-AL84 (antibody)

RRID:AB_2665406

This polyclonal targets PRLR

View all literature mentions

anti-JAK2 AL33 (antibody)

RRID:AB_2665398

This polyclonal targets JAK2

View all literature mentions

AL47 Antibody (antibody)

RRID:AB_2661849

This polyclonal targets GHR

View all literature mentions

GST (B-14) (antibody)

RRID:AB_627677

This monoclonal targets GST (B-14)

View all literature mentions

PRL-R (H-300) (antibody)

RRID:AB_2237692

This polyclonal targets DDR1

View all literature mentions

anti-GHR cyt-mAb (antibody)

RRID:AB_2665408

This monoclonal targets GHR residues 271-620

View all literature mentions

anti-GHR ext-mAb (antibody)

RRID:AB_2665407

This monoclonal targets Rabbit GHR residues 1-245

View all literature mentions